日本におけるジェノタイプ1b・高ウイルス量のC型慢性肝炎に対するコンセンサス・インターフェロンの費用対効果

Shuichi Kaneko, Masashi Unoura, Masayu Takeuchi, Shuichi Terasaki, Hidero Ogino, Eiki Matsushita, Kenichi Kobayashi, The role of hepatitis C virus in hepatocellular carcinoma in Japan. Intervirology. ,vol. 37, pp. 108- 113 ,(1994) , 10.1159/000150364

M. Ryu, Y. Shimamura, T. Kinoshita, M. Konishi, N. Kawano, M. Iwasaki, J. Furuse, M. Yoshino, N. Moriyama, M. Sugita, Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Japanese Journal of Clinical Oncology. ,vol. 27, pp. 251- 257 ,(1997) , 10.1093/JJCO/27.4.251

Kenshi Hayashida, Ichiro Nagasue, Takashi Fukuda, Atsuaki Gunji, The natural history model of hepatitis C virus infection and the economic evaluation of alpha interferon treatment. Journal of Epidemiology. ,vol. 12, pp. 22- 32 ,(2002) , 10.2188/JEA.12.22

Kenji Ikeda, Satoshi Saitoh, Isao Koida, Yasuji Arase, Akihito Tsubota, Kazuaki Chayama, Hiromitus Kumada, Masahiro Kawanishi, A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis Hepatology. ,vol. 18, pp. 47- 53 ,(1993) , 10.1002/HEP.1840180109

Keitaro Tanaka, Hironori Sakai, Makoto Hashizume, Tomio Hirohata, A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis. Japanese Journal of Cancer Research. ,vol. 89, pp. 1241- 1250 ,(1998) , 10.1111/J.1349-7006.1998.TB00520.X

Michiko Shindo, Arai Ken, Tadao Okuno, Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy. Cancer. ,vol. 85, pp. 1943- 1950 ,(1999) , 10.1002/(SICI)1097-0142(19990501)85:9<1943::AID-CNCR10>3.0.CO;2-F

William G Bennett, Yuji Inoue, J Robert Beck, John B Wong, Stephen G Pauker, Gary L Davis, Estimates of the Cost-Effectiveness of a Single Course of Interferon-α2b in Patients with Histologically Mild Chronic Hepatitis C Annals of Internal Medicine. ,vol. 127, pp. 855- 865 ,(1997) , 10.7326/0003-4819-127-10-199711150-00001

Kenji Ikeda, Satoshi Saitoh, Yasuji Arase, Kazuaki Chayama, Yoshiyuki Suzuki, Masahiro Kobayashi, Akihito Tsubota, Mizuho Kobayashi, Ikuo Nakamura, Naoya Murashima, Hiromitsu Kumada, Masahiro Kawanishi, Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology. ,vol. 29, pp. 1124- 1130 ,(1999) , 10.1002/HEP.510290439

Iwao Ikai, Yoshio Yamaoka, Yuzo Yamamoto, Nobuhiro Ozaki, Yoshiharu Sakai, Seiji Satoh, Niobuhiko Shinkura, Masayuki Yamamoto, Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Annals of Surgery. ,vol. 227, pp. 433- 439 ,(1998) , 10.1097/00000658-199803000-00016

Susumu Takano, Osamu Yokosuka, Fumio Imazeki, Masami Tagawa, Masao Omata, Incidence of hepatocellular carcinoma in chronic Hepatitis B and C: A prospective study of 251 patients Hepatology. ,vol. 21, pp. 650- 655 ,(1995) , 10.1002/HEP.1840210308